Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.
about
The interplay between the microbiome and the adaptive immune response in cancer developmentThe roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunityCytokine-Induced Modulation of Colorectal CancerThe Hen or the Egg: Inflammatory Aspects of Murine MPN ModelsThe Newly Identified T Helper 22 Cells Lodge in LeukemiaThe gastrointestinal tumor microenvironmentIL-17 family: cytokines, receptors and signalingRole of TH17 cytokines in the control of colorectal cancerThe role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancerIL-17 mediated inflammation promotes tumor growth and progression in the skinMitochondrial genome instability and ROS enhance intestinal tumorigenesis in APC(Min/+) micePathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice.Deficient import of acetyl-CoA into the ER lumen causes neurodegeneration and propensity to infections, inflammation, and cancerCCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer.Bacterial oncogenesis in the colonStat6 Promotes Intestinal Tumorigenesis in a Mouse Model of Adenomatous Polyposis by Expansion of MDSCs and Inhibition of Cytotoxic CD8 Response.Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis.Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophagesA protective role by interleukin-17F in colon tumorigenesis.T helper 17 cells play a critical pathogenic role in lung cancer.Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis.Th17 cells in cancer: help or hindrance?Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.Interplay between DNA repair and inflammation, and the link to cancerOral interleukin-10 alleviates polyposis via neutralization of pathogenic T-regulatory cellsHuman papillomavirus infection correlates with inflammatory Stat3 signaling activity and IL-17 level in patients with colorectal cancer.Human colon carcinogenesis is associated with increased interleukin-17-driven inflammatory responses.Effects of hemin and nitrite on intestinal tumorigenesis in the A/J Min/+ mouse model.Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis.IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4(+) T cells and promoting CTL persistence in a murine model of plasmacytomaTh17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cellsTpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation.Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapyA novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis.Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model.Inflammation and colorectal cancer: colitis-associated neoplasia.More than two decades of Apc modeling in rodentsNAG-1/GDF15 transgenic mouse has less white adipose tissue and a reduced inflammatory response.
P2860
Q26745703-BD9E4211-567C-48AE-BC7B-37B498E2082BQ26750673-4FB9180A-E8AB-4846-A96B-2798ADB72B0DQ26752374-CED1CAA8-A0C7-4CCC-98A4-A5A5ED01EFF3Q26778931-6850DD48-B74C-47DE-BFE5-9D61E25FDFF4Q26799454-83365A25-9F4A-46A1-B8AD-82D08843BEB3Q26827391-9E34B1B4-3AD4-451C-B4E9-BE8FAE2AB95AQ26860251-7E8E261D-379D-4EFD-B961-C8210F372D7FQ26860784-0066FA90-2475-4BBA-8CE7-A0BBD079D927Q27004062-5445A356-FF91-477B-A1F0-FCFBB51B008FQ28480915-D720158A-856D-4523-84A2-ED6536963E28Q28730326-A72876D7-28F3-4410-979A-BC08BB641909Q31133887-E4110552-0000-4528-8539-74C6E58ADC5EQ33605735-7AC2A417-46ED-4BB5-9D54-49BEE66B4E83Q33670321-47D8D5A0-1FB8-4A56-9C2D-3F22892E4E7DQ33707487-C3E669CA-CDED-4DB8-9C4A-8BA7EA2F8B81Q33737879-3C50E3C8-D78D-4287-8382-930448B6E439Q33842749-48BAE112-CB41-4DA2-B708-B424A0EC67E5Q33928256-9136308D-9F7D-4132-9A53-A61DC4ECF364Q34119854-67E182C6-4DAD-4A5F-BB87-B13BA79A8037Q34235509-E43BD87A-A521-43A2-B40C-DD080B7916C6Q34413917-FD0E22A3-F172-4F4F-8754-0699D0CB153DQ34745617-91A38068-041C-4A67-AC29-CDB770B2C365Q34913808-5995B8A6-1DE0-4FB4-92BF-8F5DA94BA7A1Q34969719-7BC88744-713D-4716-A31B-7E84CD69F09AQ34989590-552FF5D7-8DE3-4F70-A01E-C999F9D27283Q35067193-49896738-24DF-4DEE-A4E3-2B92404A8D33Q35112546-F8FD9849-29A4-4F81-87A7-946ACBB1AD0EQ35209789-AD81C106-3D7B-4F13-BBFB-767F9910C4B2Q35251212-A1832A6E-07E4-4ABD-8851-A8298510D27AQ35539983-8DBE8805-6402-4E13-A344-48C24D13DD7CQ35799158-2EC6CF8B-16BF-49A5-A786-C42ED6B93861Q35824820-FA0B55FA-D9F3-400E-A6F9-1392315BC340Q35931795-4BABE984-5625-4630-BEC7-282BC781C58FQ35935751-A1717DC9-DE90-4AF1-BC04-1EBA0CA42654Q36068286-999C2DB4-D6B9-4943-B604-CFD028AD37BFQ36080701-08B0DED6-0CA7-43F6-81E5-8DEA448760C1Q36209842-4E9F0FFB-44BB-47F5-B9E3-8AF8BAA9E4C0Q36597803-21A25596-2D9B-4A8D-9918-86C008B204C4Q36847248-C40E67B3-B3FC-4116-BF0A-A7C816E93B17Q36869509-5FBD3235-081A-43E6-B388-950922095512
P2860
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.
@ast
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.
@en
type
label
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.
@ast
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.
@en
prefLabel
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.
@ast
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.
@en
P2093
P2860
P356
P1476
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.
@en
P2093
Alfred L M Bothwell
Daniel Zelterman
Liming Hao
Octavian Henegariu
Thomas F Gibson
Wook-Jin Chae
P2860
P304
P356
10.1073/PNAS.0912675107
P407
P577
2010-03-08T00:00:00Z